Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.

Publication Type:

Journal Article

Source:

Journal of the neurological sciences, Volume 373, p.339-341 (2017)

Abstract:

Aggressive immunosuppression followed by autologous hematopoietic stem cell transplantation (aHSCT) can be an effective treatment for severe multiple sclerosis (MS), but not all stages of disease may benefit equally. The case of a 49-year-old woman with advanced secondary-progressive MS whose clinical course was not improved by aHSCT and who seven years after transplantation succumbed to complications of severe MS disease-related disability is presented. Autopsy findings of ongoing neurodegeneration despite only rare infiltrating T-lymphocytes illustrate that late MS disease may not represent a suitable disease stage for aHSCT.